Objectives

After participating in this educational activity, attendees should be able to:

1. Identify and describe an increasingly important class of medications in medicine

2. Understand the potential role of JAK inhibitors for the treatment of a spectrum of diseases including Alopecia Areata, Vitiligo, and Sarcoidosis

3. Understand the potential adverse effects of JAK inhibitors

Faculty 

Brett King, MD, PhD

Associate Professor of Dermatology/Yale School of Medicine

                                                                                                                                                                                                                                                                                                                                                          

Faculty Disclosure
None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.  

Dr. King has the following disclosures:

Consultant: SELF: Aclaris Therapeutics, Arena Pharmaceuticals, Concert Pharmaceuticals Inc, Dermavant Sciences, Eli Lilly and Company, and Pfizer Inc; SPOUSE: Pfizer

Speaker’s Bureau: SELF and SPOUSE: Pfizer, Regeneron, Sanofi Genzume

Other: SELF: Investigator for Concert Pharmaceuticals Inc, Eli Lilly and Company, and Pfizer Inc. Advisory boards for Aclaris Therapeutics, Arena Pharmaceuticals, Dermavant Sciences, and Pfizer Inc.     SPOUSE: Ad boards for Pfizer

               

 

 

Session date: 
Wednesday, December 4, 2019 - 8:00am to 9:00am
Location: 
Baystate Medical Center
759 Chestnut Street
Springfield, MA 01199
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.